Target intelligence / Profile preview

Solute carrier family 35 member H1 (SLC35H1)

Target
SLC35H1
Molecular classification
Transporter
01

Overview

Solute carrier family 35 member H1 (SLC35H1) is a nucleotide sugar transporter protein primarily localized in the membrane of the Golgi apparatus and endoplasmic reticulum[1][4]. It regulates glycosylation by shuttling activated sugars from the cytosol into organellar lumens, thus supporting cellular glycoprotein synthesis and processing. SLC35H1 expression is regulated by oxygen tension, with increased levels observed in hypoxic contexts, including trophoblast cells. It has also been highlighted for its overexpression in certain ovarian tumors, suggesting a role in cancer development and potential use as a biomarker[4]. The molecular mechanisms, clinical impact, and therapeutic modulation remain incompletely understood, as direct drug interactions or modulatory strategies are not yet established in the literature[2][4][1]. If greater granularity or recent drug development data are needed, further database queries or wet-lab literature reviews may be warranted given the limited clinical translation to date.

Other names
SLC35C2OVCOV1Ovarian cancer-overexpressed gene 1 proteinC20orf5CGI-15BA394O2.1bA394O2.1
02

Mechanism of action

None available, as no drugs targeting SLC35H1 have clinical characterization or published mechanistic data in relation to this transporter[2][4].

03

Biological functions

Nucleotide sugar transportGlycosylation regulationPutative roles in oxygen-regulated cellular adaptation
04

Disease associations

Cancer
05

Safety considerations

No direct safety concerns or therapeutic challenges reportedPotential risks may relate to off-target glycosylation effects if future inhibitors or modulators are developed
06

Biomarkers

Ovarian cancer biomarker

Beyond the preview

Go deeper on Solute carrier family 35 member H1 (SLC35H1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 35 member H1 (SLC35H1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call